IP

I don’t believe in an IP-free world, but exceptional circumstances call for exceptional responses. There is a strong case – both moral and pragmatic – to ease intellectual property restrictions on COVID vaccines. Pharmaceutical companies still need to recover R&D investments, but governments also invested heavily in Coronavirus vaccine development, as well as the rDNA science on which many vaccines are based. Loosening IP protections, which the US government now supports, would allow global manufacturing to scale more rapidly, thus increasing access to the vaccine for more than 7 billion people who still need it. Millions of lives are at stake.

— Wayne Visser

From Purpose Inspired: Reflections on Conscious Living, Volume 5. Buy on Lulu ↗